Corona Remedies shares rose 3% after a strong IPO debut, reflecting investor confidence in the pharmaceutical firm’s business strategy and…
Read More

Corona Remedies shares rose 3% after a strong IPO debut, reflecting investor confidence in the pharmaceutical firm’s business strategy and…
Read More